Marka R. Crittenden

6.6k citations
106 papers · 4.0k indexed · h-index 37
Topics
Cancer Immunotherapy and Biomarkers (63 papers)Immunotherapy and Immune Responses (42 papers)CAR-T cell therapy research (23 papers)
Journals
Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Marka R. Crittenden

103 papers receiving 4.0k citations

Peers

Marka R. Crittenden
Comparison fields: 5 of 103
  • Oncology 2.8k
  • Immunology 2.4k
  • Molecular Biology 719
  • Pulmonary and Respiratory Medicine 583
  • Radiology, Nuclear Medicine and Imaging 323
Replace Simon J. Dovedi with:
Simon J. Dovedi United Kingdom
Byron Burnette United States
Andrew B. Sharabi United States
Diego Chowell United States
Thomas E. Darga United States
Mala Chakraborty United States
Liufu Deng China
Ainhoa Arina United States
Marlon C. Rebelatto United States
Alexander Schmittel Germany
Marka R. Crittenden relative to Simon J. Dovedi United Kingdom Simon J. Dovedi's profile →
Citations per field
00.5×1.5×2.3×
Simon J. Dovedi · 1×
Citations per year

Countries citing papers authored by Marka R. Crittenden

Since Specialization
Citations

This map shows the geographic impact of Marka R. Crittenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marka R. Crittenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marka R. Crittenden more than expected).

Fields of papers citing papers by Marka R. Crittenden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marka R. Crittenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marka R. Crittenden. The network helps show where Marka R. Crittenden may publish in the future.

Co-authorship network of co-authors of Marka R. Crittenden

This figure shows the co-authorship network connecting the top 25 collaborators of Marka R. Crittenden. A scholar is included among the top collaborators of Marka R. Crittenden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marka R. Crittenden. Marka R. Crittenden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 22
3 6
4 22
5 170
6 120
7 48
8 23
9 50
10 19
11 54
12 201
13 88
14 47
15 114
16 47
17 51
18 46
19 33
20
End results and mortality trends in cancer. II. Cancer mortality trends in the United States, 1930-1955.
24

About Marka R. Crittenden

Marka R. Crittenden is a scholar working on Immunology, Oncology and Otorhinolaryngology, having authored 106 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (63 papers), Immunotherapy and Immune Responses (42 papers) and CAR-T cell therapy research (23 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (2.8k citations) and Otorhinolaryngology (123 citations). Marka R. Crittenden has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Michael J. Gough, Kristina H. Young, Jason R. Baird, Benjamin Cottam, Shelly Bambina, David J. Friedman, Brendan D. Curti, Pippa Newell, Walter J. Urba and Richard G. Vile. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026